Bowen J, Fenton T, Rappaport L
Division of Ambulatory Pediatrics, Children's Hospital, Boston, Mass 02115.
Am J Dis Child. 1991 Mar;145(3):291-5. doi: 10.1001/archpedi.1991.02160030059021.
Fifty-eight children receiving stimulant medication for attention deficit-hyperactivity disorder at referral clinics for learning disabilities at two teaching hospitals in Massachusetts were invited to participate in a study of their knowledge and attitudes. The 45 respondents and parents completed separate questionnaires concerning how they felt about receiving stimulant medication. Eighty-nine percent of the children felt that the medication was helpful and 78% liked or were indifferent to it despite a high rate (85%) of reported side effects. The five children (11%) who responded that they would stop taking stimulant medication if they could were more likely to perceive the medication as unhelpful and were receiving standard methylphenidate hydrochloride rather than a long-acting preparation. We conclude that children's perspectives on medication should be elicited directly and sustained-release medication may be more acceptable to children with attention deficit-hyperactivity disorder.
在马萨诸塞州两家教学医院的学习障碍转诊诊所，58名因注意力缺陷多动障碍而接受兴奋剂药物治疗的儿童受邀参与一项关于他们的知识和态度的研究。45名儿童及其家长分别填写了关于他们对接受兴奋剂药物治疗感受的问卷。尽管报告的副作用发生率很高（85%），但89%的儿童认为药物有帮助，78%的儿童喜欢或对其无动于衷。回答说如果可以就会停止服用兴奋剂药物的5名儿童（11%）更有可能认为药物没有帮助，且他们服用的是标准盐酸哌甲酯而非长效制剂。我们得出结论，应直接了解儿童对药物的看法，长效药物可能更容易被患有注意力缺陷多动障碍的儿童接受。
